Acetylcysteine Nixed for Prevention of Contrast-Induced Nephropathy - Internal Medicine News Digital Network PDF Print
Internal Medicine News Digital Network
Three-quarters of ACT participants had diabetes or a history of renal failure, the two main risk factors for CIN. The dosing of acetylcysteine in ACT was

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.